Spontaneous regression of EBV-associated diffuse lymphoproliferative disease in a patient with rheumatoid arthritis after discontinuation of etanercept treatment

被引：18

作者：

Park, Sung-Hoon ^{[1
]}

Kim, Chae-Gi ^{[1
]}

Kim, Ji-Young ^{[1
]}

Choe, Jung-Yoon ^{[1
]}

机构：

[1] Catholic Univ, Daegu Sch Med, Dept Internal Med, Taegu 705718, South Korea

来源：

RHEUMATOLOGY INTERNATIONAL | 2008年 / 28卷 / 05期

关键词：

rheumatoid arthritis (RA); etanercept; lymphoproliferative disease (LPD); Epstein-Barr virus (EBV);

D O I：

10.1007/s00296-007-0467-6

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

We describe the case of a 64-year-old female patient with rheumatoid arthritis (RA), who presented with lymphoproliferative disease (LPD) soon after the administration of etanercept, and regressed very shortly after the withdrawal of it. The occurrence was also associated with the Epstein-Barr virus (EBV) infection. The case of our patient may provide the evidence that etanercept plays an etiologic role in LPD in patients with RA.

引用

页码：475 / 477

页数：3

共 14 条

[1] Rheumatoid arthritis and malignant lymphomas [J].

Baecklund, E ;

Askling, J ;

Rosenquist, R ;

Ekbom, A ;

Klareskog, L .

CURRENT OPINION IN RHEUMATOLOGY, 2004, 16 (03) :254-261

[2] Association of chronic inflammation, not its treatment, with increased lymphoma risk in rheumatoid arthritis [J].

Baecklund, E ;

Iliadou, A ;

Askling, J ;

Ekborn, A ;

Backlin, C ;

Granath, F ;

Catrina, AT ;

Rosenquist, R ;

Feltelius, N ;

Sundström, C ;

Klareskog, L .

ARTHRITIS AND RHEUMATISM, 2006, 54 (03) :692-701

[3] Anti-TNF antibody therapy in rheumatoid arthritis and the risk of serious infections and malignancies - Systematic review and meta-analysis of rare harmful effects in randomized controlled trials [J].

Bongartz, T ;

Sutton, AJ ;

Sweeting, MJ ;

Buchan, I ;

Matteson, EL ;

Montori, V .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (19) :2275-2285

[4] Epidemiology of lymphoma development in patients with rheumatoid arthritis [J].

Ekbom, A .

SEMINARS IN ARTHRITIS AND RHEUMATISM, 2005, 34 (05) :28-30

[5] Tumour necrosis factor blockers do not increase overall tumour risk in patients with rheumatoid arthritis, but may be associated with an increased risk of lymphomas [J].

Geborek, P ;

Bladström, A ;

Turesson, C ;

Gulfe, A ;

Petersson, IF ;

Saxne, T ;

Olsson, H ;

Jacobsson, LTH .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (05) :699-703

[6] THE NATURAL-HISTORY OF INITIALLY UNTREATED LOW-GRADE NON-HODGKINS LYMPHOMAS [J].

HORNING, SJ ;

ROSENBERG, SA .

NEW ENGLAND JOURNAL OF MEDICINE, 1984, 311 (23) :1471-1475

[7]

Hoshida Y, 2007, J RHEUMATOL, V34, P322

[8]

MIYAZAKI T, 2007, IN PRESS AM J HEMATO

[9] A review of Epstein-Barr virus infection in patients with immunodeficiency disorders [J].

Okano, M ;

Gross, TG .

AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2000, 319 (06) :392-396

[10]

Quartuccio L, 2006, HAEMATOLOGICA, V91, P691

← 1 2 →